Uncovering Cancer’s Deepest Vulnerabilities

We provide CLIA/CAP next-generation sequencing (NGS) services and testing solutions to help develop and deliver personalized and precision diagnostics.

Our services include

Co-development Services

Our breakthrough NGS technology, diagnostic development expertise and collaborative culture makes us ideal partners for life science companies developing new, targeted therapies that require a companion diagnostic.

Clinical Research Services

We have a global footprint of external partner NGS services that are cutting-edge, CLIA-certified and CAP-accredited.

menu home-icon-silhouette remove-button twitter linkedin-1 facebook-circular-logo right